✦ LIBER ✦

Guidelines for the restart of imiglucerase in patients with Gaucher disease: Recommendations from the European Working Group on Gaucher disease

✍ Scribed by Carla E.M. Hollak; Johannes M.F.G. Aerts; Nadia Belmatoug; Bruno Bembi; Olaf Bodamer; Domenica Cappellini; Tanya Collin-Histed; Timothy M. Cox; Patrick Deegan; Pilar Giraldo; Derralynn Hughes; Elena Lukina; Jeremy Manuel; Helen Michelakakis; Maja Di Rocco; Ashok Vellodi; Ari Zimran

Book ID: 116304733
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 110 KB
Volume: 44
Category: Article
ISSN: 1079-9796
DOI: 10.1016/j.bcmd.2009.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effect of imiglucerase in Lati

Long-term effect of imiglucerase in Latin American children with Gaucher disease type 1: lessons from the International Collaborative Gaucher Group Gaucher Registry

✍ Camelo Jr, Jose Simon ;Cabello, Juan Francisco ;Drelichman, Guillermo G ;Kersten 📂 Article 📅 2014 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 459 KB

Specialist valve clinics: recommendation

Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease

✍ Chambers, J. B.; Ray, S.; Prendergast, B.; Taggart, D.; Westaby, S.; Grothier, L 📂 Article 📅 2013 🏛 BMJ 🌐 English ⚖ 78 KB

Recommendations for Competitive Sports P

Recommendations for Competitive Sports Participation in Athletes With Cardiovascular Disease: A Consensus Document From the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology

✍ A. Pelliccia; R. Fagard; H.H. Bjøornstad 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Clinical practice guidelines for managin

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

✍ B. Kasiske; F.G. Cosio; J. Beto; K. Bolton; B.M. Chavers; R. Grimm Jr.; A. Levin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula

✍ Richard B. Freeman Jr.; Robert G. Gish; Ann Harper; Gary L. Davis; John Vierling 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Determining need for liver transplantation (LT) can be effectively estimated when the actual liver disease is highly likely to cause death in the near future. However, for many conditions, the liver disease itself does not carry a high risk of short-term mortality, and other factors contribute to de

Peri-operative management of antiplatele

Peri-operative management of antiplatelet therapy in patients with coronary artery disease : Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC)

✍ Korte, W.; Cattaneo, M.; Chassot, P.-G.; Eichinger, S.; von Heymann, C.; Hofmann 📂 Article 📅 2011 🏛 Schattauer 🌐 English ⚖ 423 KB